Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Long-Term Deferred Tax: 2018-2021

Historic Long-Term Deferred Tax for Legend Biotech (LEGN) over the last 4 years, with Dec 2021 value amounting to $22.8 million.

  • Legend Biotech's Long-Term Deferred Tax fell 25.98% to $22.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $22.8 million, marking a year-over-year decrease of 25.98%. This contributed to the annual value of $22.8 million for FY2021, which is 25.98% down from last year.
  • Legend Biotech's Long-Term Deferred Tax amounted to $22.8 million in FY2021, which was down 25.98% from $30.8 million recorded in FY2020.
  • Over the past 5 years, Legend Biotech's Long-Term Deferred Tax peaked at $68.9 million during FY2018, and registered a low of $5.7 million during FY2019.
  • In the last 3 years, Legend Biotech's Long-Term Deferred Tax had a median value of $22.8 million in 2021 and averaged $19.8 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first plummeted by 91.71% in 2019, then spiked by 438.86% in 2020.
  • Legend Biotech's Long-Term Deferred Tax (Yearly) stood at $68.9 million in 2018, then tumbled by 91.71% to $5.7 million in 2019, then soared by 438.86% to $30.8 million in 2020, then decreased by 25.98% to $22.8 million in 2021.